Quarterly report pursuant to sections 13 or 15(d)

Going Concern

v2.4.0.8
Going Concern
9 Months Ended
Dec. 31, 2013
Going Concern  
Going Concern

NOTE 8 – GOING CONCERN

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As shown in the accompanying financial statements, the Company has incurred cumulative net losses of $47,711 from January 30, 2012 (cumulative period from inception) to December 31, 2013. The Company completed a merger transaction on January 15, 2014 with Ekso Bionics, Inc., an operating company, which currently has sufficient capital to finance operations through the next twelve months.  The Company continues to have no revenues and very limited working capital as of December 31, 2013.